BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38709660)

  • 1. Evaluation of the Contrast Enhancement Performance of Gadopiclenol for Magnetic Resonance Angiography in Healthy Rabbits and Pigs.
    Hugon G; Adriaensen H; Wintrebert M; Arnould L; Serfaty JM; Robert P
    Invest Radiol; 2024 May; ():. PubMed ID: 38709660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast-to-Dose Relationship of Gadopiclenol, an MRI Macrocyclic Gadolinium-based Contrast Agent, Compared with Gadoterate, Gadobenate, and Gadobutrol in a Rat Brain Tumor Model.
    Robert P; Vives V; Grindel AL; Kremer S; Bierry G; Louin G; Ballet S; Corot C
    Radiology; 2020 Jan; 294(1):117-126. PubMed ID: 31660804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Gadopiclenol and P846, 2 High-Relaxivity Macrocyclic Magnetic Resonance Contrast Agents Without Protein Binding, in a Rodent Model of Hepatic Metastases: Potential Solutions for Improved Enhancement at Ultrahigh Field Strength.
    Fries P; Massmann A; Robert P; Corot C; Laschke MW; Schneider G; Buecker A; Müller A
    Invest Radiol; 2019 Sep; 54(9):549-558. PubMed ID: 31033675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast-enhanced magnetic resonance angiography: evaluation of the high relaxivity low diffusible gadolinium-based contrast agent P846 in comparison with gadoterate meglumine in rabbits at 1.5 Tesla and 3.0 Tesla.
    Peldschus K; Hamdorf M; Robert P; Port M; Graessner J; Adam G; Herborn CU
    Invest Radiol; 2008 Dec; 43(12):837-42. PubMed ID: 19002055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic and static magnetic resonance angiography of the supra-aortic vessels at 3.0 T: intraindividual comparison of gadobutrol, gadobenate dimeglumine, and gadoterate meglumine at equimolar dose.
    Kramer JH; Arnoldi E; François CJ; Wentland AL; Nikolaou K; Wintersperger BJ; Grist TM
    Invest Radiol; 2013 Mar; 48(3):121-8. PubMed ID: 23211552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast-enhanced magnetic resonance angiography in rabbits: evaluation of the gadolinium-based agent p846 and the iron-based blood pool agent p904 in comparison with gadoterate meglumine.
    Kinner S; Maderwald S; Parohl N; Albert J; Corot C; Robert P; Barkhausen J; Vogt FM
    Invest Radiol; 2011 Aug; 46(8):524-9. PubMed ID: 21577130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of Brain Metastases by Contrast-Enhanced MRI: Comparison of Gadopiclenol and Gadobenate in a Mouse Model.
    Robert P; Vives V; Rasschaert M; Hao J; Soares M; Lemaître M; Dencausse A; Catoen S
    Invest Radiol; 2024 Feb; 59(2):131-139. PubMed ID: 37921777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Gadolinium Distribution of the New High-Relaxivity Gadolinium Chelate Gadopiclenol in a Rat Model of Severe Renal Failure.
    Fretellier N; Rasschaert M; Bocanegra J; Robert P; Factor C; Seron A; Idée JM; Corot C
    Invest Radiol; 2021 Dec; 56(12):826-836. PubMed ID: 34091462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small Brain Lesion Enhancement and Gadolinium Deposition in the Rat Brain: Comparison Between Gadopiclenol and Gadobenate Dimeglumine.
    Violas X; Rasschaert M; Santus R; Factor C; Corot C; Catoen S; Idée JM; Robert P
    Invest Radiol; 2022 Feb; 57(2):130-139. PubMed ID: 34411032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MR angiography of carotid artery aneurysms in a porcine model at 3 Tesla: comparison of two different macrocyclic gadolinium chelates and of dynamic and conventional techniques.
    Wuesten O; Morelli JN; Miller MW; Tuzun E; Lenox MW; Fossum TW; Trelles M; Cotes C; Krombach GA; Runge VM
    J Magn Reson Imaging; 2012 Nov; 36(5):1203-12. PubMed ID: 22826184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous acquisition of MR angiography and diagnostic images of abdomen at view-sharing multiarterial phases and comparing the effect of two different contrast agents.
    Noda Y; Goshima S; Namimoto T; Shinkawa N; Nakagawa M; Kajita K; Kawada H; Kawai N; Tanahashi Y; Matsuo M; Bae KT; Hirai T; Yamashita Y
    J Magn Reson Imaging; 2018 Jul; 48(1):102-110. PubMed ID: 29247585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative evaluation of lesion enhancement using 1 M gadobutrol vs. 2 conventional gadolinium chelates, all at a dose of 0.1 mmol/kg, in a rat brain tumor model at 3 T.
    Attenberger UI; Runge VM; Jackson CB; Baumann S; Birkemeier K; Michaely HJ; Schoenberg SO; Reiser MF; Wintersperger BJ
    Invest Radiol; 2009 May; 44(5):251-6. PubMed ID: 19550376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose Finding Study of Gadopiclenol, a New Macrocyclic Contrast Agent, in MRI of Central Nervous System.
    Bendszus M; Roberts D; Kolumban B; Meza JA; Bereczki D; San-Juan D; Liu BP; Anzalone N; Maravilla K
    Invest Radiol; 2020 Mar; 55(3):129-137. PubMed ID: 31917762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extremely Small Pseudoparamagnetic Iron Oxide Nanoparticle as a Novel Blood Pool T1 Magnetic Resonance Contrast Agent for 3 T Whole-Heart Coronary Angiography in Canines: Comparison With Gadoterate Meglumine.
    Park EA; Lee W; So YH; Lee YS; Jeon BS; Choi KS; Kim EG; Myeong WJ
    Invest Radiol; 2017 Feb; 52(2):128-133. PubMed ID: 27977466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Safety of Gadopiclenol for Contrast-Enhanced MRI of the Central Nervous System: The PICTURE Randomized Clinical Trial.
    Loevner LA; Kolumban B; Hutóczki G; Dziadziuszko K; Bereczki D; Bago A; Pichiecchio A
    Invest Radiol; 2023 May; 58(5):307-313. PubMed ID: 36729404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signal Enhancement and Enhancement Kinetics of Gadobutrol, Gadoteridol, and Gadoterate Meglumine in Various Body Regions: A Comparative Animal Study.
    Knobloch G; Frenzel T; Pietsch H; Jost G
    Invest Radiol; 2020 Jun; 55(6):367-373. PubMed ID: 31985602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Benefits of High Relaxivity for Brain Tumor Imaging: Results of a Multicenter Intraindividual Crossover Comparison of Gadobenate Dimeglumine with Gadoterate Meglumine (The BENEFIT Study).
    Vaneckova M; Herman M; Smith MP; Mechl M; Maravilla KR; Weichet J; Spampinato MV; Žižka J; Wippold FJ; Baima JJ; Babbel R; Bültmann E; Huang RY; Buhk JH; Bonafé A; Colosimo C; Lui S; Kirchin MA; Shen N; Pirovano G; Spinazzi A
    AJNR Am J Neuroradiol; 2015 Sep; 36(9):1589-98. PubMed ID: 26185325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR Angiography at 3 T of Peripheral Arterial Disease: A Randomized Prospective Comparison of Gadoterate Meglumine and Gadobutrol.
    Loewe C; Arnaiz J; Krause D; Marti-Bonmati L; Haneder S; Kramer U;
    AJR Am J Roentgenol; 2015 Jun; 204(6):1311-21. PubMed ID: 26001243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement characteristics and impact on image quality of two gadolinium chelates at equimolar doses for time-resolved 3-Tesla MR-angiography of the calf station.
    Hansmann J; Michaely HJ; Morelli JN; Luckscheiter A; Schoenberg SO; Attenberger UI
    PLoS One; 2014; 9(6):e99079. PubMed ID: 24893292
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.